Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01851161 · ClinicalTrials.gov registry record

Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy

A clinical trial, sponsored by Virginia Commonwealth University.

Terminated
Registry status
23
Enrollment target

NCT01851161: Clinical Trial study, sponsored by Virginia Commonwealth University.

NCT01851161 is a clinical trial that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01851161 was terminated before completion, sponsored by Virginia Commonwealth University.

TERMINATED
Registry status
23 participants
Enrollment target

Study Summary

This clinical trial studies prone patient positioning in reducing tumor motion and improving breathing reproduction in patients with lung cancer undergoing radiation therapy. Prone patient positioning during radiation therapy may help kill tumor cells without harming normal tissue.

Primary Outcome

During the 4D CT patient respiration trace will be recorded using the RPM optical tracking device. The average and standard deviation of the amplitude, period, end of inhalation position, and end of exhalation position of the respiration trace will be calculated. Paired t tests and F tests will be used to evaluate differences between these quantities for supine and prone positioning.

Interventions

  • PROCEDURE computed tomography
  • RADIATION radiation therapy
  • PROCEDURE 4-dimensional computed tomography

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2010-05
Est. Completion 2015-09
Virginia Commonwealth University

558 total trials

Why NCT01851161 stopped before completion

NCT01851161 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.

The record links to 0 conditions, and to 3 interventions - of which computed tomography is the first listed.

NCT01851161 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01851161 about?

NCT01851161 is a clinical study titled "Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy". This clinical trial studies prone patient positioning in reducing tumor motion and improving breathing reproduction in patients with lung cancer undergoing radiation therapy. Prone patient positioning during radiation therapy may help kill tumor cells without harming normal tissue.

What is the current status of trial NCT01851161?

This trial is currently terminated. The enrollment target is 23 participants. The study started on 2010-05. Estimated completion is 2015-09.

What interventions are being tested in trial NCT01851161?

The interventions under investigation include: computed tomography (PROCEDURE), radiation therapy (RADIATION), 4-dimensional computed tomography (PROCEDURE).

Who is sponsoring clinical trial NCT01851161?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01851161, the US trial registry maintained by the National Library of Medicine. NCT01851161 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.